Episurf Medical (NASDAQ: EPIS B) has during the last year received seven additional patent approval notifications.

The United States Patent and Trademark Office (USPTO) has issued three notices of allowance. Two of them relate to positioning features to ensure correct implantation of the company's Episealer® implants, while the third relates to a system for customising an implant for treatment of damage in an anatomical joint.

The Indian patent office Intellectual Property India has granted the company three new patents in India. One patent covers design automation as part of Episurf's implant production, one relates to design of surgical drill guides, and the third is for an osteotomy guide as part of Episurf's technology for ankle implants.

Lastly, the Swedish patent office PRV has during the year approved a patent application for implants of the patellofemoral part of the knee joint, to address dysplastic knees. This is the first approval in this patent family.

"With this, we summarise the year that has passed as a strong year for Episurf's patent portfolio. While the US market is extremely important for us, we are continuing ensuring proper patent protection for the different products the company has developed, in several markets", comments Katarina Flodström, COO, Episurf Medical.